Global Remicade Biosimilar Market Research Report 2021
- Published Date: 2021-02-27
- Report ID: 63770
- Pages: 150
-
Format:
Prudent Markets Predicts that Remicade Biosimilar Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Remicade Biosimilar Market Overview:
Global Remicade Biosimilar Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Remicade Biosimilar involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Remicade Biosimilar Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Remicade Biosimilar market in 2020.
Global Remicade Biosimilar Market Segmentation
By Type, Remicade Biosimilar market has been segmented into:
100mg/10ml
500mg/50ml
Other
By Application, Remicade Biosimilar market has been segmented into:
Blood Disorders
Oncology Diseases
Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Remicade Biosimilar market are:
Teva Pharmaceutical Industries
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
1. Market Overview of Remicade Biosimilar
1.1 Remicade Biosimilar Market Overview
1.1.1 Remicade Biosimilar Product Scope
1.1.2 Market Status and Outlook
1.2 Remicade Biosimilar Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Remicade Biosimilar Historic Market Size by Regions (2015-2020)
1.4 Remicade Biosimilar Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Remicade Biosimilar Sales Market by Type (2015-2026)
2.1 Global Remicade Biosimilar Historic Market Size by Type (2015-2020)
2.2 Global Remicade Biosimilar Forecasted Market Size by Type (2021-2026)
2.3 100mg/10ml
2.4 500mg/50ml
2.5 Other
3. Covid-19 Impact Remicade Biosimilar Sales Market by Application (2015-2026)
3.1 Global Remicade Biosimilar Historic Market Size by Application (2015-2020)
3.2 Global Remicade Biosimilar Forecasted Market Size by Application (2021-2026)
3.3 Blood Disorders
3.4 Oncology Diseases
3.5 Other
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Remicade Biosimilar Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Remicade Biosimilar Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Remicade Biosimilar Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Remicade Biosimilar Business
5.1 Teva Pharmaceutical Industries
5.1.1 Teva Pharmaceutical Industries Company Profile
5.1.2 Teva Pharmaceutical Industries Remicade Biosimilar Product Specification
5.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Synthon Pharmaceuticals
5.2.1 Synthon Pharmaceuticals Company Profile
5.2.2 Synthon Pharmaceuticals Remicade Biosimilar Product Specification
5.2.3 Synthon Pharmaceuticals Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 LG Life Sciences
5.3.1 LG Life Sciences Company Profile
5.3.2 LG Life Sciences Remicade Biosimilar Product Specification
5.3.3 LG Life Sciences Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Novartis (Sandoz)
5.4.1 Novartis (Sandoz) Company Profile
5.4.2 Novartis (Sandoz) Remicade Biosimilar Product Specification
5.4.3 Novartis (Sandoz) Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Celltrion
5.5.1 Celltrion Company Profile
5.5.2 Celltrion Remicade Biosimilar Product Specification
5.5.3 Celltrion Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Biocon
5.6.1 Biocon Company Profile
5.6.2 Biocon Remicade Biosimilar Product Specification
5.6.3 Biocon Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Hospira
5.7.1 Hospira Company Profile
5.7.2 Hospira Remicade Biosimilar Product Specification
5.7.3 Hospira Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Merck Serono (Merck Group)
5.8.1 Merck Serono (Merck Group) Company Profile
5.8.2 Merck Serono (Merck Group) Remicade Biosimilar Product Specification
5.8.3 Merck Serono (Merck Group) Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Biogen idec Inc.
5.9.1 Biogen idec Inc. Company Profile
5.9.2 Biogen idec Inc. Remicade Biosimilar Product Specification
5.9.3 Biogen idec Inc. Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Genentech (Roche Group)
5.10.1 Genentech (Roche Group) Company Profile
5.10.2 Genentech (Roche Group) Remicade Biosimilar Product Specification
5.10.3 Genentech (Roche Group) Remicade Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Remicade Biosimilar Market Size (2015-2026)
6.2 North America Remicade Biosimilar Key Players in North America (2015-2020)
6.3 North America Remicade Biosimilar Market Size by Type (2015-2020)
6.4 North America Remicade Biosimilar Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Remicade Biosimilar Market Size (2015-2026)
7.2 East Asia Remicade Biosimilar Key Players in North America (2015-2020)
7.3 East Asia Remicade Biosimilar Market Size by Type (2015-2020)
7.4 East Asia Remicade Biosimilar Market Size by Application (2015-2020)
8. Europe
8.1 Europe Remicade Biosimilar Market Size (2015-2026)
8.2 Europe Remicade Biosimilar Key Players in North America (2015-2020)
8.3 Europe Remicade Biosimilar Market Size by Type (2015-2020)
8.4 Europe Remicade Biosimilar Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Remicade Biosimilar Market Size (2015-2026)
9.2 South Asia Remicade Biosimilar Key Players in North America (2015-2020)
9.3 South Asia Remicade Biosimilar Market Size by Type (2015-2020)
9.4 South Asia Remicade Biosimilar Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Remicade Biosimilar Market Size (2015-2026)
10.2 Southeast Asia Remicade Biosimilar Key Players in North America (2015-2020)
10.3 Southeast Asia Remicade Biosimilar Market Size by Type (2015-2020)
10.4 Southeast Asia Remicade Biosimilar Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Remicade Biosimilar Market Size (2015-2026)
11.2 Middle East Remicade Biosimilar Key Players in North America (2015-2020)
11.3 Middle East Remicade Biosimilar Market Size by Type (2015-2020)
11.4 Middle East Remicade Biosimilar Market Size by Application (2015-2020)
12. Africa
12.1 Africa Remicade Biosimilar Market Size (2015-2026)
12.2 Africa Remicade Biosimilar Key Players in North America (2015-2020)
12.3 Africa Remicade Biosimilar Market Size by Type (2015-2020)
12.4 Africa Remicade Biosimilar Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Remicade Biosimilar Market Size (2015-2026)
13.2 Oceania Remicade Biosimilar Key Players in North America (2015-2020)
13.3 Oceania Remicade Biosimilar Market Size by Type (2015-2020)
13.4 Oceania Remicade Biosimilar Market Size by Application (2015-2020)
14. South America
14.1 South America Remicade Biosimilar Market Size (2015-2026)
14.2 South America Remicade Biosimilar Key Players in North America (2015-2020)
14.3 South America Remicade Biosimilar Market Size by Type (2015-2020)
14.4 South America Remicade Biosimilar Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Remicade Biosimilar Market Size (2015-2026)
15.2 Rest of the World Remicade Biosimilar Key Players in North America (2015-2020)
15.3 Rest of the World Remicade Biosimilar Market Size by Type (2015-2020)
15.4 Rest of the World Remicade Biosimilar Market Size by Application (2015-2020)
16 Remicade Biosimilar Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
